Steven Cohen’s Yarrow Bioscience YARW Stock Holding History

Steven Cohen’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-59	Closed	-$352K	–	1153
2020 Q3	$352K	Buy	+59	New	+$344K	﹤0.01%	844
2020 Q2	–	Sell	-278	Closed	-$2.68M	–	1045
2020 Q1	$2.68M	Buy	+278	New	+$4.36M	0.02%	469

Other funds holding YARW

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Steven Cohen's YARW Position: Q4 2020 in Review

Steven Cohen sold out of Yarrow Bioscience (YARW) in Q4 2020, closing a stake of 59 shares — an estimated $352K sold.

Steven Cohen first reported a position in YARW in Q1 2020 and held it in 2 quarters. The position peaked at $2.68M in Q1 2020. 98 funds tracked by Wall St. Rank hold YARW as of Q4 2020.

Steven Cohen reported no remaining Yarrow Bioscience position as of Q4 2020 after selling out during the quarter.
Steven Cohen sold 59 Yarrow Bioscience shares in Q4 2020, an estimated $352K.
Steven Cohen first reported a position in Yarrow Bioscience in Q1 2020 and held it in 2 quarters.
Steven Cohen's Yarrow Bioscience position peaked at $2.68M in Q1 2020.
98 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2020.

Based on Point72 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.